Sunday, June 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home European Markets

Sivers Semiconductors Faces a Defining May as Short Sellers Circle and Nasdaq Ambitions Intensify

Rodolfo Hanigan by Rodolfo Hanigan
May 7, 2026
in European Markets, Semiconductors, Tech & Software, Trading & Momentum
0
Sivers Semiconductors Stock
0
SHARES
78
VIEWS
Share on FacebookShare on Twitter

The blistering rally in Sivers Semiconductors shares — a 725% surge over the past twelve months — has drawn the attention of two prominent hedge funds now betting against the stock. Voleon Capital Management and Two Sigma Investments have both built short positions in the Swedish technology group within the last 48 hours, signaling that some on Wall Street view the near-$1 billion market capitalization as increasingly detached from fundamentals.

The skepticism is not without basis. While Sivers grew revenue by 33% to $39 million in its most recent fiscal year, the company has yet to achieve consistent profitability. That gap between valuation and earnings performance has become a flashpoint as the group pursues an ambitious dual listing on the Nasdaq in New York — a move that is already complicating its financial reporting calendar.

A Pivotal Fortnight Ahead

May is shaping up to be the most consequential month in Sivers’ recent history. The company has delayed the release of its annual report to May 15, citing the need for an “audit uplift” to align its accounts with US standards. The annual general meeting has been pushed back to June 15 as a result. Before that, shareholders will gather for an extraordinary meeting on May 11 to vote on a targeted share issuance of up to 8.62 million new shares, with proceeds earmarked for research and development in AI data centers and satellite communications.

Just five days after the annual report lands, on May 20, Sivers will publish its first-quarter results — a critical test of whether the operational momentum can justify the stock’s elevated multiple.

Should investors sell immediately? Or is it worth buying Sivers Semiconductors?

New Deal Provides Tangible Support

Amid the corporate calendar crunch, Sivers has secured a fresh commercial win that bolsters its near-term narrative. The company announced a $1.5 million development partnership with US-based Tachyon Networks to co-develop a 60 GHz transceiver for fixed wireless networks. The deal deepens an existing relationship; Tachyon had previously ordered antenna modules worth $3 million from Sivers.

Harish Krishnaswamy, who heads Sivers’ wireless business, described the expanded collaboration as a low-risk, fast-track route for customers to deploy high-capacity short-range links in dense urban environments. Tachyon CEO Hal Bledsoe echoed that sentiment, noting the partnership provides a clear pathway for network expansion.

Valuation Under the Microscope

The Tachyon contract offers concrete evidence of commercial traction, but the market’s expectations remain extraordinarily high. Sivers currently trades at 31 times sales — a stark contrast to the European semiconductor sector average of roughly four times revenue, and well above the multiples of its direct peers.

The short sellers’ arrival adds a layer of tension to an already packed schedule. With the capital raise, the accounting overhaul, the Nasdaq listing preparations, and now the quarterly numbers all converging within a two-week window, Sivers must deliver results that justify the hype — or risk seeing the bears take control.

Ad

Sivers Semiconductors Stock: Buy or Sell?! New Sivers Semiconductors Analysis from June 14 delivers the answer:

The latest Sivers Semiconductors figures speak for themselves: Urgent action needed for Sivers Semiconductors investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 14.

Sivers Semiconductors: Buy or sell? Read more here...

Tags: Sivers Semiconductors
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Microsoft Stock
Dividends

Microsoft’s Stock Struggles Despite 40% Azure Growth and a $190B AI Bet

June 14, 2026
BMW Stock
Automotive & E-Mobility

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Amazon Stock
Analysis

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

June 14, 2026
Next Post
Almonty Stock

Almonty Lands a Heavyweight Investor and a New Finance Chief Just as Its Korean Mine Starts to Deliver

CSG Stock

CSG Systems Posts Blowout Q1 Earnings Even as NEC Takeover Looms

Microsoft Stock

Xbox Chief Axes Copilot Plans as Microsoft Pivots From Gaming to Grid-Scale AI

Recommended

MP Materials Stock

A Strategic Shift for MP Materials: New Alliances and Major Investor Moves

7 months ago
Lynas Stock

Lynas Shares Defy Production Woes on Analyst Confidence

6 months ago
Telecommunications Industry Stock Exchange

PCCW Global Revolutionizing IoT Connectivity with Innovative Solutions

2 years ago
MSCI World ETF Stock

The AI Boom Reshapes a Core Global ETF

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

Amazon’s Freight Gambit and Regulatory Headwinds Eclipse Prime Day Hype

OHB’s Record Backlog and a Shifting Shareholder Base Set the Stage for a Defining Summer

Germany’s Communities Feel the Squeeze as Labour Shortage Forecast Worsens by 1.3 Million

European Lithium Faces a Trio of Hurdles as Lithium Markets Show Signs of Turning

Trending

Microsoft Stock
Dividends

Microsoft’s Stock Struggles Despite 40% Azure Growth and a $190B AI Bet

by Rodolfo Hanigan
June 14, 2026
0

The disconnect between Microsoft’s operating strength and its share price has rarely been starker. The software giant...

Novo Nordisk Stock

Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape

June 14, 2026
BMW Stock

BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

June 14, 2026
Uranium Energy Stock

Uranium Energy’s $52 Million Quarter: No Revenue, a New Texas Mine, and a $794 Million Cushion

June 14, 2026
Ocugen Stock

Ocugen Faces a Moment of Truth as Clinical Catalysts Collide With a 55% Plunge

June 14, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Microsoft’s Stock Struggles Despite 40% Azure Growth and a $190B AI Bet
  • Novo Nordisk Sharpens Its Pipeline Edge as Longevity Pivot Takes Shape
  • BMW Executive Puts Money on Recovery After Stock Plunge, as Electric M-Concept Unveiled at Le Mans

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com